CureVac N.V. (CVAC) – Hot FDA News
-
CureVac N.V. (CVAC) and GSK (GSK) Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
-
CureVac N.V. (CVAC) Second-Gen COVID-19 Candidate, CV2CoV, Demonstrates Comparable Antibody Levels to Licensed mRNA Vaccine - Publication
-
-
-
-
-
-
-
-
Back to CVAC Stock Lookup